%0 Consensus Development Conference
%T Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: a consensus-based SIE, SIES, GITMO position paper.
%A Barosi G
%A Vannucchi AM
%A De Stefano V
%A Pane F
%A Passamonti F
%A Rambaldi A
%A Saglio G
%A Barbui T
%A Tura S
%J Leuk Res
%V 38
%N 2
%D Feb 2014
%M 24378116
%F 3.715
%R 10.1016/j.leukres.2013.09.008
%X This article presents the results of group discussion among experts from SIE, SIES and GITMO societies aimed at highlighting unmet challenges in the management of Ph-neg myeloproliferative neoplasms (MPNs). The issues analyzed were: diagnosis of prefibrotic myelofibrosis; diagnosis of Ph-neg MPNs in the setting of splanchnic vein thrombosis (SVT); management of low-risk PV and low-risk ET patients with JAK2V617F mutation; molecular biomarkers in the prognostic evaluation of myelofibrosis (MF); ruxolitinib therapy in low-risk MF; therapy in patients with SVT-associated Ph-neg MPN; indications of splenectomy in MF. For each of these issues, proposals for advancement in clinical research were addressed.